• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种形式的DNA拓扑异构酶II表达的生长状态和细胞周期依赖性波动以及M期高分子量形式的可能特异性修饰。

Growth state- and cell cycle-dependent fluctuation in the expression of two forms of DNA topoisomerase II and possible specific modification of the higher molecular weight form in the M phase.

作者信息

Kimura K, Saijo M, Ui M, Enomoto T

机构信息

Department of Physiological Chemistry, Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.

出版信息

J Biol Chem. 1994 Jan 14;269(2):1173-6.

PMID:8288578
Abstract

The fluctuations in the expression of two forms of DNA topoisomerase II, p170 and p180, were examined by immunoblotting during the transition of the growth state and the cell cycle in Swiss 3T3 cells. The level of p170 expression was higher during the exponentially growing phase than in the stationary phase, and the level of p180 did not appear to change when the cells changed the growth state. When quiescent cells were stimulated with serum, the p170 level began to increase at 12 h and reached a maximal level at 24-28 h, corresponding to the G2 phase. In contrast, the level of p180 was almost constant during the cell cycle, and the p180 band became obscure when the number of mitotic cells increased. Immunoblotting of the samples prepared from metaphase-synchronized HeLa cells did not have a p180 band, but did exhibit a band with a higher molecular weight. This band increased and p180 decreased in parallel with the increase in the number of mitotic cells. When the cells exited from the M phase, p180 reappeared and the higher molecular weight band disappeared.

摘要

通过免疫印迹法检测了瑞士3T3细胞在生长状态和细胞周期转变过程中两种形式的DNA拓扑异构酶II(p170和p180)表达的波动情况。在指数生长期,p170的表达水平高于静止期,当细胞改变生长状态时,p180的水平似乎没有变化。当静止细胞受到血清刺激时,p170水平在12小时开始升高,并在24 - 28小时达到最高水平,这与G2期相对应。相比之下,p180的水平在细胞周期中几乎保持恒定,当有丝分裂细胞数量增加时,p180条带变得模糊不清。从中期同步化的HeLa细胞制备的样品进行免疫印迹时,没有p180条带,但确实显示出一条分子量更高的条带。随着有丝分裂细胞数量的增加,这条带增加而p180减少。当细胞从M期退出时,p180重新出现,分子量更高的条带消失。

相似文献

1
Growth state- and cell cycle-dependent fluctuation in the expression of two forms of DNA topoisomerase II and possible specific modification of the higher molecular weight form in the M phase.两种形式的DNA拓扑异构酶II表达的生长状态和细胞周期依赖性波动以及M期高分子量形式的可能特异性修饰。
J Biol Chem. 1994 Jan 14;269(2):1173-6.
2
Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II.
Biochemistry. 1989 Oct 3;28(20):8154-60. doi: 10.1021/bi00446a029.
3
Growth state and cell cycle dependent phosphorylation of DNA topoisomerase II in Swiss 3T3 cells.瑞士3T3细胞中DNA拓扑异构酶II的生长状态和细胞周期依赖性磷酸化
Biochemistry. 1992 Jan 21;31(2):359-63. doi: 10.1021/bi00117a007.
4
Topoisomerase-specific drug sensitivity in relation to cell cycle progression.
Mol Cell Biol. 1987 Sep;7(9):3119-23. doi: 10.1128/mcb.7.9.3119-3123.1987.
5
Identification of the nature of modification that causes the shift of DNA topoisomerase II beta to apparent higher molecular weight forms in the M phase.
J Biol Chem. 1994 Oct 7;269(40):24523-6.
6
Association between the p170 form of human topoisomerase II and progeny viral DNA in cells infected with herpes simplex virus type 1.人类拓扑异构酶II的p170形式与单纯疱疹病毒1型感染细胞中病毒子代DNA之间的关联
J Virol. 1994 Feb;68(2):1010-20. doi: 10.1128/JVI.68.2.1010-1020.1994.
7
Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme.从氨吖啶抗性P388白血病细胞中纯化拓扑异构酶II。该酶两种形式的证据。
J Biol Chem. 1987 Dec 5;262(34):16739-47.
8
Cell cycle phase-specific phosphorylation of human topoisomerase II alpha. Evidence of a role for protein kinase C.
J Biol Chem. 1995 Nov 24;270(47):28357-63. doi: 10.1074/jbc.270.47.28357.
9
The distribution of immunoreactive topoisomerase II Protein in human tissues and neoplasms.免疫反应性拓扑异构酶II蛋白在人体组织和肿瘤中的分布。
Oncol Res. 1992;4(4-5):157-66.
10
Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells.
Cell Growth Differ. 1991 Apr;2(4):209-14.

引用本文的文献

1
Telling Your Right Hand from Your Left: The Effects of DNA Supercoil Handedness on the Actions of Type II Topoisomerases.辨别左右手:DNA 超螺旋手性对 II 型拓扑异构酶作用的影响。
Int J Mol Sci. 2023 Jul 7;24(13):11199. doi: 10.3390/ijms241311199.
2
Investigating the Anticancer Potential of Salvicine as a Modulator of Topoisomerase II and ROS Signaling Cascade.研究沙尔威辛作为拓扑异构酶II和ROS信号级联调节剂的抗癌潜力。
Front Oncol. 2022 Jun 1;12:899009. doi: 10.3389/fonc.2022.899009. eCollection 2022.
3
Control of topoisomerase II activity and chemotherapeutic inhibition by TCA cycle metabolites.
三羧酸循环代谢物对拓扑异构酶 II 活性的控制和化疗抑制。
Cell Chem Biol. 2022 Mar 17;29(3):476-489.e6. doi: 10.1016/j.chembiol.2021.08.014. Epub 2021 Sep 15.
4
Optimization of New Catalytic Topoisomerase II Inhibitors as an Anti-Cancer Therapy.新型催化拓扑异构酶II抑制剂作为抗癌疗法的优化
Cancers (Basel). 2021 Jul 22;13(15):3675. doi: 10.3390/cancers13153675.
5
Molecular mechanisms of anthracycline cardiovascular toxicity.蒽环类药物心脏毒性的分子机制。
Clin Sci (Lond). 2021 May 28;135(10):1311-1332. doi: 10.1042/CS20200301.
6
Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics.用于抗癌治疗的新型催化性拓扑异构酶II抑制剂的发现。
Front Oncol. 2021 Feb 1;10:633142. doi: 10.3389/fonc.2020.633142. eCollection 2020.
7
Cell Cycle-Dependent Control and Roles of DNA Topoisomerase II.细胞周期依赖性控制与 DNA 拓扑异构酶 II 的作用。
Genes (Basel). 2019 Oct 30;10(11):859. doi: 10.3390/genes10110859.
8
Heat Stress-Induced DNA Damage.热应激诱导的DNA损伤。
Acta Naturae. 2016 Apr-Jun;8(2):75-8.
9
Mechanisms regulating resistance to inhibitors of topoisomerase II.调控拓扑异构酶 II 抑制剂耐药性的机制。
Front Pharmacol. 2013 Aug 1;4:89. doi: 10.3389/fphar.2013.00089. eCollection 2013.
10
Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a-/- mutants.母本拓扑异构酶IIα而非拓扑异构酶IIβ能够使斑马鱼top2a -/- 突变体进行胚胎发育。
BMC Dev Biol. 2011 Nov 23;11:71. doi: 10.1186/1471-213X-11-71.